Your institution may have access to this item. Find your institution then sign in to continue.
Title
Propranolol-resistant infantile haemangiomas.
Authors
Caussé, S; Aubert, H; Saint-Jean, M; Puzenat, E; Bursztejn, A-C; Eschard, C; Mahé, E; Maruani, A; Mazereeuw-Hautier, J; Dreyfus, I; Miquel, J; Chiaverini, C; Boccara, O; Hadj-Rabia, S; Stalder, J-F; Barbarot, S; Groupe de Recherche Clinique en Dermatologie Pédiatrique
Abstract
Propranolol is now widely used to treat severe infantile haemangiomas (IHs). Very few cases of propranolol-resistant IH (PRIH) are mentioned in the literature.
Publication
The British journal of dermatology, 2013, Vol 169, Issue 1, p125